Skip to content

Endoscopic gastric cancer risk score and the clinical application value of new optical staining techniques

Endoscopic gastric cancer risk score and the clinical application value of new optical staining techniques

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039111
Enrollment
Unknown
Registered
2020-10-17
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric precancerous disease and early cancer

Interventions

Gold Standard:Observe the lesion under endoscopy and take a biopsy for pathological examination, the pathological result is the gold standard.
Index test:1.New&#32
dyeing&#32
technology&#32
SFI/VIST&#32
of&#32
Sonoscape&#32
550
2.Endoscopic&#32
cancer&#32
risk&#32
3.Endoscopic&#32

Sponsors

The First Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Those who underwent gastroscopy at the First Hospital of Hebei Medical University, the Tenth People's Hospital Affiliated to Tongji University, and the Second Affiliated Hospital of Soochow University, aged 18-80 years old who meet the indications for gastroscopy and can undergo pathological biopsy; 2. The patient needs to sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of gastric surgery; 2. Patients with incomplete clinical data; 3. Patients with other malignant tumors; 4. Patients with endoscopic intolerance; 5. Patients with coagulation dysfunction or who can't get biopsy after taking anticoagulant drugs recently.

Design outcomes

Primary

MeasureTime frame
Types of Gastritis;atrophy;Intestinal metaplasia score;recancerous lesions;Diffuse redness;SEN, SPE, ACC, AUC of ROC, PPV, NPV;

Secondary

MeasureTime frame
Nodular gastritis;Fold enlargement;

Countries

??

Contacts

Public ContactJing Wang

The First Hospital of Hebei Medical University

ydyynjzx@126.com+86 18633889832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026